COMPASS Pathways plc (CMPS)
NASDAQ: CMPS · Real-Time Price · USD
4.990
+0.260 (5.50%)
At close: Feb 5, 2025, 4:00 PM
5.08
+0.09 (1.80%)
Pre-market: Feb 6, 2025, 4:40 AM EST
COMPASS Pathways Market Cap
COMPASS Pathways has a market cap or net worth of $341.42 million as of February 6, 2025. Its market cap has decreased by -31.31% in one year.
Market Cap
341.42M
Enterprise Value
167.02M
1-Year Change
-31.31%
Ranking
Category
Stock Price
$4.99
Market Cap Chart
Since the IPO on September 18, 2020, COMPASS Pathways's market cap has decreased from $568.58M to $341.42M, a decrease of -39.95%. That is a compound annual growth rate of -10.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2025 | 323.63M | 25.13% |
| Dec 31, 2024 | 258.63M | -52.25% |
| Dec 29, 2023 | 541.59M | 58.41% |
| Dec 30, 2022 | 341.89M | -62.93% |
| Dec 31, 2021 | 922.26M | -46.12% |
| Dec 31, 2020 | 1.71B | 201.05% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.74B |
| UnitedHealth Group | 504.48B |
| Novo Nordisk | 367.70B |
| Johnson & Johnson | 365.65B |
| AbbVie | 336.00B |
| Merck & Co. | 252.43B |
| Thermo Fisher Scientific | 227.11B |
| Abbott Laboratories | 222.79B |